SM
Schedule 13G filing
Sumitomo Mitsui Trust Group, Inc. disclosed a 5.9% stake in ARCT
Sumitomo Mitsui Trust Group, Inc. reported owning 5.9% of Arcturus Therapeutics Holdings Inc. (ARCT) (1,689,107 shares) in a Schedule 13G filed Oct 29, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 29, 2026
- Source
- Schedule 13G
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.